Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Current Assets: 2017-2024

Historic Current Assets for Arcus Biosciences (RCUS) over the last 8 years, with Dec 2024 value amounting to $1.0 billion.

  • Arcus Biosciences' Current Assets fell 23.96% to $857.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $857.0 million, marking a year-over-year decrease of 23.96%. This contributed to the annual value of $1.0 billion for FY2024, which is 22.26% up from last year.
  • Arcus Biosciences' Current Assets amounted to $1.0 billion in FY2024, which was up 22.26% from $831.0 million recorded in FY2023.
  • In the past 5 years, Arcus Biosciences' Current Assets registered a high of $1.3 billion during FY2021, and its lowest value of $735.8 million during FY2020.
  • For the 3-year period, Arcus Biosciences' Current Assets averaged around $971.3 million, with its median value being $1.0 billion (2024).
  • Its Current Assets has fluctuated over the past 5 years, first surged by 281.83% in 2020, then decreased by 22.12% in 2023.
  • Over the past 5 years, Arcus Biosciences' Current Assets (Yearly) stood at $735.8 million in 2020, then surged by 71.51% to $1.3 billion in 2021, then declined by 15.45% to $1.1 billion in 2022, then fell by 22.12% to $831.0 million in 2023, then increased by 22.26% to $1.0 billion in 2024.